Skip to main content
. 2021 Mar 13;60(12):5734–5742. doi: 10.1093/rheumatology/keab242

Table 1.

Baseline characteristics compared according to depression symptom categories

‘None’ (n = 374) Mild (n = 192) Moderate–severe (n = 176) P-value
Age, mean (s.d.), years 45.3 (14.6) 45.5 (13.6) 45.5 (12.8) 0.97
Males, n (%) 248 (66) 133 (69) 115 (65) 0.69
Meeting modified New York criteria, n (%) 221 (59) 118 (61) 96 (55) 0.40
Age at symptom onset, mean (s.d.), years 28.0 (10.7) 29.5 (12.2) 29.4 (12.3) 0.21
Symptom duration, mean (s.d.), years 17.3 (13.4) 16.0 (12.5) 16.1 (13.1) 0.43
HLA-B27 positive, n (%) 218 (78) 106 (75) 90 (70) 0.23
BMI, mean (s.d.), kg/m2 27.2 (5.2) 29.0 (6.1) 28.8 (6.5) 0.002
Education, n (%)
 Secondary school 107 (29) 71 (37) 22 (50) 0.006
 Apprenticeship 36 (10) 16 (8) 4 (9)
 Further education college 110 (29) 62 (33) 15 (34)
 University degree 93 (25) 34 (18) 2 (5)
 Further degree 28 (7) 7 (4) 1 (2)
IMD, mean (s.d.) 2.9 (1.4) 3.1 (1.4) 3.3 (1.4) 0.004
NSAID use in past 6 months, n (%) 277 (75) 138 (74) 123 (71) 0.62
DMARD use in past 6 months, n (%) 44 (12) 25 (14) 38 (22) 0.009
ASDAS, mean (s.d.) 2.6 (0.8) 3.1 (0.7) 3.3 (0.7) <0.001
BASDAI, median (IQR) 6.0 (4.5, 7.2) 7.0 (6.0, 7.8) 7.7 (6.9, 8.9) <0.001
Spinal pain, median (IQR) 6.0 (4.0, 7.0) 7.0 (6.0, 8.0) 8.0 (6.0, 9.0) <0.001
BASFI, median (IQR) 5.4 (3.3, 7.0) 6.9 (5.4, 8.3) 8.1 (6.8, 9.1) <0.001
ASQoL, median (IQR) 10.0 (7.0, 13.0) 14.0 (12.0, 16.0) 16.0 (14.0, 17.0) <0.001
Fatiguea, median (IQR) 15.0 (12.0, 19.0) 18.0 (16.0, 22.0) 22.0 (18.0, 26.5) <0.001
History of physician diagnosed depression, n (%) 31 (8) 31 (16) 51 (29) <0.001

aThe Chalder Fatigue Scale ranges from 0 (low) to 33 (high). ASDAS: AS disease activity score; ASQoL: AS quality of life questionnaire; BASDAI: Bath AS disease activity index; BASFI: Bath AS functional index; IMD: index of multiple deprivation with 1 (least deprived) to 5 (most); IQR: interquartile range.